TipRanks
Klaviyo, Wingstop among Stephens Best Ideas for 2026
📈
AI Sentiment
Highly Positive
9/10
- Home
- TECH
TECH
Bio-Techne Corp
as of 01-06-2026 3:42pm EST
$65.28
+$2.25
+3.57%
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
| Founded: | 1976 | Country: | United States |
| Employees: | N/A | City: | MINNEAPOLIS |
| Market Cap: | 9.2B | IPO Year: | 1989 |
| Target Price: | $70.46 | AVG Volume (30 days): | 1.6M |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.49 | EPS Growth: | -48.73 |
| 52 Week Low/High: | $46.01 - $79.28 | Next Earning Date: | 02-04-2026 |
| Revenue: | $1,216,732,000 | Revenue Growth: | 3.85% |
| Revenue Growth (this year): | 2.33% | Revenue Growth (next year): | 7.05% |
AI-Powered TECH Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 72.00%
72.00%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Bio-Techne Corp News
TECH Breaking Stock News: Dive into TECH Ticker-Specific Updates for Smart Investing
StockStory
Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH)
âž–
AI Sentiment
Neutral
4/10
Compare TECH vs Leading Stocks
See how TECH stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TECH Bio-Techne Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.